Matches in SemOpenAlex for { <https://semopenalex.org/work/W2774420072> ?p ?o ?g. }
- W2774420072 endingPage "791.e6" @default.
- W2774420072 startingPage "777" @default.
- W2774420072 abstract "Monoclonal antibodies (mAbs) can destroy tumors by recruiting effectors such as myeloid cells, or targeting immunomodulatory receptors to promote cytotoxic T cell responses. Here, we examined the therapeutic potential of combining a direct tumor-targeting mAb, anti-CD20, with an extended panel of immunomodulatory mAbs. Only the anti-CD27/CD20 combination provided cures. This was apparent in multiple lymphoma models, including huCD27 transgenic mice using the anti-huCD27, varlilumab. Detailed mechanistic analysis using single-cell RNA sequencing demonstrated that anti-CD27 stimulated CD8+ T and natural killer cells to release myeloid chemo-attractants and interferon gamma, to elicit myeloid infiltration and macrophage activation. This study demonstrates the therapeutic advantage of using an immunomodulatory mAb to regulate lymphoid cells, which then recruit and activate myeloid cells for enhanced killing of mAb-opsonized tumors." @default.
- W2774420072 created "2017-12-22" @default.
- W2774420072 creator A5003367418 @default.
- W2774420072 creator A5007119947 @default.
- W2774420072 creator A5009112007 @default.
- W2774420072 creator A5020755903 @default.
- W2774420072 creator A5027079457 @default.
- W2774420072 creator A5029987869 @default.
- W2774420072 creator A5039728880 @default.
- W2774420072 creator A5040796674 @default.
- W2774420072 creator A5045952465 @default.
- W2774420072 creator A5050997547 @default.
- W2774420072 creator A5054814390 @default.
- W2774420072 creator A5058616423 @default.
- W2774420072 creator A5061182152 @default.
- W2774420072 creator A5062215182 @default.
- W2774420072 creator A5073058385 @default.
- W2774420072 creator A5074087478 @default.
- W2774420072 creator A5074279762 @default.
- W2774420072 creator A5076688601 @default.
- W2774420072 creator A5080784325 @default.
- W2774420072 creator A5080987183 @default.
- W2774420072 creator A5082666045 @default.
- W2774420072 creator A5088169325 @default.
- W2774420072 date "2017-12-01" @default.
- W2774420072 modified "2023-10-06" @default.
- W2774420072 title "Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid Recruitment" @default.
- W2774420072 cites W1487073651 @default.
- W2774420072 cites W1493841666 @default.
- W2774420072 cites W1571451553 @default.
- W2774420072 cites W1581194007 @default.
- W2774420072 cites W1590618281 @default.
- W2774420072 cites W1616189793 @default.
- W2774420072 cites W1675831178 @default.
- W2774420072 cites W1758612015 @default.
- W2774420072 cites W1880141119 @default.
- W2774420072 cites W1934768104 @default.
- W2774420072 cites W1944461161 @default.
- W2774420072 cites W1971222772 @default.
- W2774420072 cites W1973575640 @default.
- W2774420072 cites W1977099733 @default.
- W2774420072 cites W1983922088 @default.
- W2774420072 cites W1985266211 @default.
- W2774420072 cites W1993468695 @default.
- W2774420072 cites W1998605540 @default.
- W2774420072 cites W2005915548 @default.
- W2774420072 cites W2006554573 @default.
- W2774420072 cites W2009109361 @default.
- W2774420072 cites W2023776610 @default.
- W2774420072 cites W2023930907 @default.
- W2774420072 cites W2024857291 @default.
- W2774420072 cites W2028182878 @default.
- W2774420072 cites W2036995752 @default.
- W2774420072 cites W2048787440 @default.
- W2774420072 cites W2051803876 @default.
- W2774420072 cites W2052374585 @default.
- W2774420072 cites W2061123122 @default.
- W2774420072 cites W2063987509 @default.
- W2774420072 cites W2072460663 @default.
- W2774420072 cites W2075785757 @default.
- W2774420072 cites W2098193186 @default.
- W2774420072 cites W2102776587 @default.
- W2774420072 cites W2108556253 @default.
- W2774420072 cites W2109900474 @default.
- W2774420072 cites W2111110781 @default.
- W2774420072 cites W2113170011 @default.
- W2774420072 cites W2114104545 @default.
- W2774420072 cites W2117281169 @default.
- W2774420072 cites W2134216732 @default.
- W2774420072 cites W2135608944 @default.
- W2774420072 cites W2141484788 @default.
- W2774420072 cites W2162472186 @default.
- W2774420072 cites W2162743871 @default.
- W2774420072 cites W2165051502 @default.
- W2774420072 cites W2167709430 @default.
- W2774420072 cites W2168706273 @default.
- W2774420072 cites W2228540040 @default.
- W2774420072 cites W2380566153 @default.
- W2774420072 cites W2468096222 @default.
- W2774420072 cites W2550794796 @default.
- W2774420072 cites W2563543508 @default.
- W2774420072 cites W2611196568 @default.
- W2774420072 cites W2614968685 @default.
- W2774420072 cites W2621711437 @default.
- W2774420072 cites W4250894669 @default.
- W2774420072 doi "https://doi.org/10.1016/j.ccell.2017.11.001" @default.
- W2774420072 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5734932" @default.
- W2774420072 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29198913" @default.
- W2774420072 hasPublicationYear "2017" @default.
- W2774420072 type Work @default.
- W2774420072 sameAs 2774420072 @default.
- W2774420072 citedByCount "49" @default.
- W2774420072 countsByYear W27744200722018 @default.
- W2774420072 countsByYear W27744200722019 @default.
- W2774420072 countsByYear W27744200722020 @default.
- W2774420072 countsByYear W27744200722021 @default.
- W2774420072 countsByYear W27744200722022 @default.
- W2774420072 countsByYear W27744200722023 @default.